GERD Device Maker’s Experience Exemplifies Coverage Barriers For Small Biz
This article was originally published in The Gray Sheet
Executive Summary
Curon Medical's five-year battle to surpass 10% of U.S. public and private insurer coverage of its Stretta GERD therapy underscores the difficulties small companies face in navigating the reimbursement process